Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03281720 · ClinicalTrials.gov registry record · NA
Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03281720 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 100 participants.
The verdict
NCT03281720, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine how feasible and accurate identifying and removing specific lymph nodes in the axilla (armpit) after neoadjuvant systemic therapy is when patients present with breast cancer that has spread to lymph nodes in the axilla. The specific lymph nodes removed would be determined at the time of diagnosis. If a biopsy proves that cancer has spread to a lymph node, a titanium clip will placed in it to mark it for future removal. That lymph node will be removed after systemic therapy and compared with the rest of the lymph nodes removed from that region.
Interventions
- PROCEDURE TAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-04-07 |
| Est. Completion | 2021-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03281720
The ClinicalTrials.gov registry entry for NCT03281720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TAD is the first listed.
NCT03281720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03281720 about?
NCT03281720 is a clinical study titled "Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases". The purpose of this research study is to determine how feasible and accurate identifying and removing specific lymph nodes in the axilla (armpit) after neoadjuvant systemic therapy is when patients present with breast cancer that has spread to lymph nodes in the axilla. The specific lymph nodes remo...
What is the current status of trial NCT03281720?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-04-07. Estimated completion is 2021-05-24.
What interventions are being tested in trial NCT03281720?
The interventions under investigation include: TAD (PROCEDURE).
Who is sponsoring clinical trial NCT03281720?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.